INS and Insulin resistance: Furthermore, DCI inhibited the activation of PKCε (i.e., a diacylglycerol-activated protein that contributes to insulin resistance) and activated the phosphoinositide-3-kinase/activates protein B [PI3K/AKT] pathway, contributing to improved insulin signaling.